Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NICE

Chance for Scotland to lead with Alzheimer’s treatment

SCOTLAND has a “golden opportunity” to lead the way in dementia care if the NHS is given the go-ahead to use a new kind of treatment.

The National (Scotland)

The Ineos Effect: hit and miss as Jim Ratcliffe’s tentacles have gone global

Ratcliffe has built an empire of assets across different sports but his teams have enjoyed varying degrees of success

The Guardian - UK

Lyme disease: What are the symptoms and how can it be treated?

Lyme Disease UK has warned that the disease is on the rise in the UK

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Mounjaro will soon be available as a weight loss treatment on the NHS – here’s what that means for patients

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.

The Conversation

Weight loss drugs shouldn’t create ‘dependency culture’, says Health Secretary

Mr Sweeting said it was in “everyone’s interest to play their part” and avoid overloading the health system.

Evening Standard

The crucial Europa League rule change which could impact Rangers' campaign

The crucial Europa League rule change in revamped league phase which could impact Rangers' campaign.

The National (Scotland)

Ousmane Dembele to Return to PSG Squad vs. Nice, per Report

Ousmane Dembélé reportedly apologized to Luis Enrique and is set to return to PSG's squad against Nice.

Sports Illustrated

Read news from The Economist, FT, and more,
with one subscription

Pressure mounts on publisher of Economist over ties to tobacco

Exclusive: Experts pull out of health conferences run by Economist Impact after revelations of commercial links

The Guardian - UK

NYT Connections today hints and answers — Thursday, September 19 (#466)

Need help with Connections #466? Here are some hints and the answers.

Tom’s Guide

Ten of the best-value deals from this summer’s transfer window

Close to £5bn was spent by Europe’s top five men’s leagues – but which players may prove to be worth the fees paid?

The Guardian - UK

Europa League and Conference League draw: As they happened

The Europa League and Conference League have drawn some fantastic fixtures for the league stage of the competition

FourFourTwo

Every footballer to have received a perfect 10 from L’Equipe: featuring Lionel Messi, Ademola Lookman and Neymar

Only 15 players in football history have achieved a perfect 10/10 match rating from the prestigious publication.

FourFourTwo

UK drug regulator approves Alzheimer's drug but government likely won't pay for it

Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact in slowing progression of the neurodegenerative disease

The Independent UK

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

NICE says drug is not cost effective and shares fears of side effects

The Independent UK

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

The Guardian - UK

UK health regulator rejects lecanemab as treatment for Alzheimer’s

Decision by Nice to rule out drug being available on NHS comes despite medicines licensing body giving green light

The Guardian - UK

Women in England to be offered a daily tablet for fibroids, Nice says

About 30,000 patients with moderate to severe symptoms could receive Linzagolix, which may shrink growths

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

One third of NHS psychosis services used to treat patients like Valdo Calocane are failing standards

Health minister Wes Streeting said Barnaby Webber, Grace O’Malley-Kumar and Ian Coates “might still be alive” today if “the NHS had been there when it should have been”

Evening Standard

Jean-Clair Todibo set for West Ham medical after loan deal agreed for £34m defender considered by Man United

Man United opted against move for Nice defender due to fears of breaching UEFA rules on multi-club ownership

The Guardian - UK

NHS to offer new drug to prevent bone fractures in postmenopausal women

Abaloparatide, which could help more than 14,000 women with osteoporosis, to be available in England within three months

The Independent UK

New drug to tackle weak bone symptom of the menopause

Abaloparatide – which is sold as Eladynos and made by Theramex – has been given the green light for NHS use

The Independent UK

Thousands of postmenopausal women to benefit from bone-strengthening drug on NHS

The treatment increases bone density by stimulating the cells that make new bone.

The Guardian - UK

ME: we need more funding and more research

Letters: people with myalgic encephalomyelitis and their carers are calling for a reversal of decades of underfunding

Top News

Manchester United In Talks For Swap Deal With Inter Milan

Stay updated with the latest transfer news as clubs in Europe engage in negotiations and potential deals during the summer transfer window.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.